Intricon Stock Price, News & Analysis
Company Description
Intricon (NASDAQ: IIN) is a publicly traded medical instruments & supplies company in the Healthcare sector. The company has a market capitalization of $225.5M.
IIN stock has declined 2.7% over the past year.
This page provides a comprehensive overview of IIN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Intricon (IIN) stock. Over the past 12 months, the stock has lost 2.7%. At a market capitalization of $225.5M, IIN is classified as a micro-cap stock with approximately 9.3M shares outstanding.
Latest News
Intricon has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings, conferences, fda approval, clinical trial. View all IIN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
IIN Company Profile & Sector Positioning
Intricon (IIN) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing IIN often look at related companies in the same sector, including Orasure Tech (OSUR), Sharps Tech (STSS), NYXOAH S A (NYXH), (BTAVF), and Infusystem Hld (INFU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IIN's relative position within its industry.